Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
Please provide your email address to receive an email when new articles are posted on . The study will evaluate whether two multicancer early detection tests improve early detection of 10 solid tumors ...
WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...
TREATMENT. THIS TEST DOCTORS HERE AT E.G.H. TELL ME IS A GAME CHANGER. IT CAN MINIMIZE LATE STAGE CANCER DIAGNOSIS AND ACTUALLY DETECT CANCER YEARS BEFORE A PATIENT WOULD HAVE EVER KNOWN WITH ONE ...
Angus is STAT’s cancer reporter. Marissa, when not working as an intern, studies extracellular vesicles in the brain in her Ph.D. research. Angus Chen covers all issues broadly related to cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback